#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)

    Recruiting

    3 1
    Investigated Drugs:
    Belgium Croatia Denmark France Germany Greece +9

  • Study of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Poland Spain

  • Study on Frexalimab, SAR442970, and Rilzabrutinib for Patients Aged 16-75 with Focal Segmental Glomerulosclerosis or Minimal Change Disease

    Recruiting

    2 1
    Investigated Diseases:
    Czechia France Germany Greece Hungary Italy +5

  • Study on the Safety and Effects of Sparsentan for Children with Proteinuric Kidney Diseases

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy The Netherlands Poland Spain Sweden

  • Efficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    Germany Italy Portugal Slovakia Spain

  • Study on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Croatia Czechia Denmark Estonia France +6

  • Study of BI 764198 for Patients with Focal Segmental Glomerulosclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Spain

  • Study on R3R01 for Patients with Alport Syndrome and Primary Steroid-Resistant Focal Segmental Glomerulosclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany The Netherlands

  • Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark France Germany Italy Portugal +1